Location History:
- Naruto, JP (2010 - 2012)
- Tokushima, JP (2014 - 2024)
Company Filing History:
Years Active: 2010-2024
Title: Koushi Iwata: Innovator in Keratoconjunctival Disorders
Introduction
Koushi Iwata is a notable inventor based in Naruto, Japan. He has made significant contributions to the field of ophthalmology, particularly in developing treatments for keratoconjunctival disorders. With a total of 7 patents to his name, Iwata's work has the potential to improve the quality of life for many individuals suffering from eye conditions.
Latest Patents
Iwata's latest patents include a protective agent for keratoconjunctiva and a suppressive agent for keratoconjunctival disorders. The objective of this invention is to provide a protective agent that exhibits an excellent suppressive effect on keratoconjunctival disorders. This invention utilizes glucosylglycerol as an active ingredient, which is aimed at protecting the keratoconjunctiva and suppressing related disorders. Another significant patent involves phenylimidazole compounds, which are disclosed along with their pharmaceutically acceptable salts. These compounds are part of a pharmaceutical composition and serve as a lipoprotein lipase activator.
Career Highlights
Throughout his career, Koushi Iwata has worked with prominent companies in the pharmaceutical industry, including Otsuka Pharmaceutical Factory, Inc. and Otsuka Pharmaceutical Company, Limited. His experience in these organizations has contributed to his expertise in developing innovative solutions for eye care.
Collaborations
Iwata has collaborated with notable colleagues such as Takashi Okamura and Tadao Shibutani. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented inventions.
Conclusion
Koushi Iwata's contributions to the field of ophthalmology through his innovative patents demonstrate his commitment to improving eye health. His work continues to pave the way for advancements in treatments for keratoconjunctival disorders.